Login / Signup
Dosing will be a key success factor in repurposing antivirals for COVID-19.
Patrick F Smith
Michael Dodds
Darren Bentley
Karen Yeo
Craig Rayner
Published in:
British journal of clinical pharmacology (2020)
Keyphrases
</>
coronavirus disease
sars cov
respiratory syndrome coronavirus